Mount Sinai ADRC: Core Satellite (Neugroschl) | PROJECT SUMMARY The overarching goal of the Satellite Core is to ensure that the Mount Sinai Alzheimer's Disease Research Center (MSADRC) has an adequate representation of minorities, particularly Latinos, as they are the predominant Underrepresented Group in our local community, and are at greater risk for dementia. Our innovative outreach programs, based on community based participatory research methodology, coupled with our flexible strategy for doing research evaluations, have made this core successful. The Satellite Core is committed to building bridges with this underserved, under represented community, to foster trust. In the upcoming cycle, we will continue to disseminate culturally and linguistically appropriate information about cognition, diabetes and dementia, and to incorporate feedback from the community to tailor outreach and recruitment efforts. We will achieve this goal by using evidence-based methods based on our research and knowledge of the neuropsychological and medical profiles of this demographic, to accurately diagnose the individuals that come into our center. We work with the Outreach Recruitment and Education (ORE) Core to disseminate information and translate new knowledge to health professionals, trainees and the lay community. The Satellite Core is responsible for the recruitment and retention of Latino participants for the MSADRC Clinical Core, to comprehensively characterize these subjects and to facilitate participation in biomarker collection and other clinical studies. The activities of the Satellite Core represent a collaborative effort involving close participation with the ORE Core and the Clinical Core and the Administrative Core, as well as a partnership with the New York State funded Alzheimer's Disease Assistance Center (ADAC). Working together, through numerous community outreach efforts including surveys and focus groups, we have been able to identify cultural barriers participation to research to create a network of community partnerships. Our Satellite Core efforts are integrated into the Clinical Core, but allow for additional community based and home based testing, effectively making it a Satellite without Walls. This strong foundation for the recruitment and retention of culturally diverse participants, allows for successful recruitment of Latino subjects, and we look forward to reaching out to other Mount Sinai communities (for example Mount Sinai Beth Israel) to expand our efforts. We have made contributions to National Alzheimer's Project Act (NAPA)'s primary goal to prevent and effectively treat AD by 2025 by increasing participation of Latinos in clinical studies, in helping to meaningfully characterize this population to facilitate the assessment and diagnosis of these individuals.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
2P50AG005138-31
Application #
8849214
Study Section
Special Emphasis Panel (ZAG1-ZIJ-5 (J1))
Project Start
Project End
Budget Start
2015-05-01
Budget End
2016-03-31
Support Year
31
Fiscal Year
2015
Total Cost
$124,705
Indirect Cost
Name
Icahn School of Medicine at Mount Sinai
Department
Type
DUNS #
078861598
City
New York
State
NY
Country
United States
Zip Code
10029
Agrawal, A; Chou, Y-L; Carey, C E et al. (2018) Genome-wide association study identifies a novel locus for cannabis dependence. Mol Psychiatry 23:1293-1302
Brenowitz, Willa D; Han, Fang; Kukull, Walter A et al. (2018) Treated hypothyroidism is associated with cerebrovascular disease but not Alzheimer's disease pathology in older adults. Neurobiol Aging 62:64-71
Dobbyn, Amanda; Huckins, Laura M; Boocock, James et al. (2018) Landscape of Conditional eQTL in Dorsolateral Prefrontal Cortex and Co-localization with Schizophrenia GWAS. Am J Hum Genet 102:1169-1184
Cruchaga, Carlos; Del-Aguila, Jorge L; Saef, Benjamin et al. (2018) Polygenic risk score of sporadic late-onset Alzheimer's disease reveals a shared architecture with the familial and early-onset forms. Alzheimers Dement 14:205-214
Alosco, Michael L; Sugarman, Michael A; Besser, Lilah M et al. (2018) A Clinicopathological Investigation of White Matter Hyperintensities and Alzheimer's Disease Neuropathology. J Alzheimers Dis 63:1347-1360
Kinnunen, Kirsi M; Cash, David M; Poole, Teresa et al. (2018) Presymptomatic atrophy in autosomal dominant Alzheimer's disease: A serial magnetic resonance imaging study. Alzheimers Dement 14:43-53
Brent, Robert J (2018) Estimating the monetary benefits of medicare eligibility for reducing the symptoms of dementia. Appl Econ 50:6327-6340
Moreno, Cesar L; Della Guardia, Lucio; Shnyder, Valeria et al. (2018) iPSC-derived familial Alzheimer's PSEN2 N141I cholinergic neurons exhibit mutation-dependent molecular pathology corrected by insulin signaling. Mol Neurodegener 13:33
Deming, Yuetiva; Dumitrescu, Logan; Barnes, Lisa L et al. (2018) Sex-specific genetic predictors of Alzheimer's disease biomarkers. Acta Neuropathol 136:857-872
Gallagher, Damien; Kiss, Alex; Lanctot, Krista L et al. (2018) Toward Prevention of Mild Cognitive Impairment in Older Adults With Depression: An Observational Study of Potentially Modifiable Risk Factors. J Clin Psychiatry 80:

Showing the most recent 10 out of 555 publications